Erratum to: Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002).

Ann Surg Oncol

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.

Published: December 2015

Download full-text PDF	Source
http://dx.doi.org/10.1245/s10434-015-4864-x	DOI Listing

Publication Analysis

erratum phase

phase trial

trial s-1

s-1 oxaliplatin

oxaliplatin cetuximab

cetuximab colorectal

colorectal cancer

cancer patients

patients initially

initially unresectable

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!